References

• 1. İstatistiklerle Yaşlılar. 2021. google scholar
• 2. Lindeman RD, Tobin J, Shock NW. Longitudinal Studies on the Rate of Decline in Renal Function with Age. J. Am. Geriatr. Soc. 1985;33. google scholar
• 3. Kappel B, Olsen S. Cortical interstitial tissue and sclerosed glomeruli in the normal human kidney, related to age and sex - A quantitative study. Virchows Arch. A Pathol. Anat. Histol. 1980;387. google scholar
• 4. Kaplan C, Pasternack B, Shah H, et al. Age related incidence of sclerotic glomeruli in human kidneys. Am. J. Pathol. 1975;80. google scholar
• 5. Bolignano D, Mattace-Raso F, Sijbrands EJG, et al. The aging kidney revisited: A systematic review. Ageing Res. Rev. 2014;14. google scholar
• 6. Yu HT. Progression of chronic renal failure. Arch. Intern. Med. 2003;163. google scholar
• 7. Taal MW. Chronic kidney disease in older people - Diagnosis, aetiology and consequences. Curr. Opin. Nephrol. Hypertens. 2015;24. google scholar
• 8. Levin A, Stevens PE, Bilous RW, et al. Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney dise-ase. Kidney Int. Suppl. 2013;3. google scholar
• 9. Mora-Gutierrez JM, Slon Roblero MF, Castano Bilbao I, et al. Enfermedad renal cronica en el paciente anciano. Rev. Esp. Geriatr. Gerontol. 2017;52. google scholar
• 10. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. J. Am. Med. Assoc. 2007;298. google scholar
• 11. Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease - A systematic review and meta-analysis. PLoS One 2016;11. google scholar
• 12. Süleymanlar G, Uta C, Arinsoy T, et al. A population-based survey of Chronic REnal Disease in Turkey-the CREDIT study. Nephrol. Dial. Transplant. 2011;26. google scholar
• 13. Chen TK, Knicely DH, Grams ME. Chronic Kidney Disease Diagnosis and Management: A Review. JAMA - J. Am. Med. Assoc. 2019;322. google scholar
• 14. Manjunath G, Tighiouart H, Coresh J, et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int. 2003;63. google scholar
• 15. Newsletter transplant. Ministerio De Sanidad, Servicios Sociales E Igualdad Gabinete De Prensa. Espana es Hder Mund. en Traspl. por 24o ano consecutivo, segun los datos del Regist. Mund. Traspl. Gest. por la ONT 2015;10. google scholar
• 16. Yokoyama H, Sugiyama H, Sato H, et al. Renal disease in the elderly and the very elderly Japanese: Analysis of the Japan Renal Biopsy Registry (J-RBR). Clin. Exp. Nephrol. 2012;16. google scholar
• 17. Sumnu A. Primary glomerular diseases in the elderly. World J. Nephrol. 2015;4. google scholar
• 18. Greco BA, Breyer JA. The natural history of renal artery stenosis: Who should be evaluated for suspected ischemic nephropathy? Semin. Nephrol. 1996;16. google scholar
• 19. Zucchelli P, Zuccala A. Ischemic nephropathy inthe elderly. Contrib. Nephrol. 1993;105. google scholar
• 20. Soares CM, Diniz JSS, Lima EM, et al. Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme. Nephrol. Dial. Transplant. 2009;24. google scholar
• 21. Kazancioğlu R. Risk factors for chronic kidney disease: An update. In: Kidney International Supplements. Vol 3. , 2013. google scholar
• 22. Young JH, Klag MJ, Muntner P, et al. Blood pressure and decline in kidney function: Findings from the Systolic Hypertension in the Elderly Program (SHEP). J. Am. Soc. Nephrol. 2002;13. google scholar
• 23. Wright JT, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA 2002;288. google scholar
• 24. O’Hare AM, Kaufman JS, Covinsky KE, et al. Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: Is the evidence base relevant to older adults? Ann. Intern. Med. 2009;150. google scholar
• 25. Weiss JW, Thorp ML, O’Hare AM. Renin-angiotensin system blockade in older adults with chronic kidney disease: A review of the literature. Curr. Opin. Nephrol. Hypertens. 2010;19. google scholar
• 26. Winkelmayer WC, Zhang Z, Shahinfar S, et al. Efficacy and safety of angiotensin II receptor blockade in elderly patients with diyalizes. Diyalizes Care 2006;29. google scholar
• 27. Rahman M, Ford CE, Cutler JA, et al. Long-Term renal and cardiovascular outcomes in antihypertensive and Lipid-Lowering treatment to prevent heart attack trial (ALLHAT) participants by baseline estimated GFR. Clin. J. Am. Soc. Nephrol. 2012;7. google scholar
• 28. Duckworth W, Abraira C, Moritz T, et al. Glucose Control and Vascular Complications in Veterans with Type 2 Diyalizes. N. Engl. J. Med. 2009;360. google scholar
• 29. Moen MF, Zhan M, Hsu VD, et al. Frequency of hypoglycemia and its significance in chronic kidney dise-ase. Clin. J. Am. Soc. Nephrol. 2009;4. google scholar
• 30. Zoungas S, Patel A, Chalmers J, et al. Severe Hypoglycemia and Risks of Vascular Events and Death. N. Engl. J. Med. 2010;363. google scholar
• 31. KDIGO 2020 Clinical Practice Guideline for Diyalizes Management in Chronic Kidney Disease. Kidney Int. 2020;98. google scholar
• 32. Cunningham J, Locatelli F, Rodriguez M. Secondary hyperparathyroidism: Pathogenesis, disease progres-sion, and therapeutic options. Clin. J. Am. Soc. Nephrol. 2011;6. google scholar
• 33. Portillo MR, Rodriguez-Ortiz ME. Secondary Hyperparthyroidism: Pathogenesis, Diagnosis, Preventive and Therapeutic Strategies. Rev. Endocr. Metab. Disord. 2017;18. google scholar
• 34. Canalejo R, Canalejo A, Martinez-Moreno JM, et al. FGF23 fails to inhibit uremic parathyroid glands. J. Am. Soc. Nephrol. 2010;21. google scholar
• 35. Munoz-Castaneda JR, Herencia C, Pendon-Ruiz de Mier MV, et al. Differential regulation of renal Klotho and FGFR1 in normal and uremic rats. FASEB J. 2017;31. google scholar
• 36. Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disea-se-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters. Kidney Int. 2017;92. google scholar
• 37. Patschan D, Patschan S, Ritter O. Chronic Metabolic Acidosis in Chronic Kidney Disease. Kidney Blood Press. Res. 2020;45. google scholar
• 38. Giordano M, Ciarambino T, Castellino P, et al. Light and shadows of dietary protein restriction in elderly with Chronic Kidney Disease. Nutrition 2013;29. google scholar
• 39. Gadelha AB, Cesari M, Correa HL, et al. Effects of pre-dialysis resistance training on sarcopenia, inflam-matory profile, and anemia biomarkers in older community-dwelling patients with chronic kidney disease: a randomized controlled trial. Int. Urol. Nephrol. 2021;53. google scholar
• 40. Ostuni M, Musso CG. Usefulness of frailty evaluation for handling chronic kidney disease elderly patients: a review and original proposal. Int. Urol. Nephrol. 2019;51. google scholar
• 41. D’alessandro C, Piccoli GB, Barsotti M, et al. Prevalence and correlates of sarcopenia among elderly CKD outpatients on tertiary care. Nutrients 2018;10. google scholar
• 42. Maw TT, Fried L. Chronic Kidney Disease in the Elderly. Clin. Geriatr. Med. 2013;29:611-624. google scholar
• 43. Schmidt IM, Hübner S, Nadal J, et al. Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: The German Chronic Kidney Disease study. Clin. Kidney J. 2019;12. google scholar
• 44. Secora A, Alexander GC, Ballew SH, et al. Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults. Drugs and Aging 2018;35. google scholar
• 45. Fick DM, Semla TP, Steinman M, et al. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J. Am. Geriatr. Soc. 2019;67. google scholar
• 46. Bahat G, Ilhan B, Erdogan T, et al. Turkish inappropriate medication use in the elderly (TIME) criteria to improve prescribing in older adults: TIME-to-STOP/TIME-to-START. Eur. Geriatr. Med. 2020;11. google scholar
• 47. Triantafylidis LK, Hawley CE, Perry LP, et al. The role of deprescribing in older adults with chronic kidney disease. Drugs and Aging 2018;35. google scholar
• 48. Wongrakpanich S, Susantitaphong P, Isaranuwatchai S, et al. Dialysis Therapy and Conservative Manage-ment of Advanced Chronic Kidney Disease in the Elderly: A Systematic Review. Nephron 2017;137. google scholar
• 49. Tamura MK, O’Hare AM, McCulloch CE, et al. Signs and symptoms associated with earlier dialysis initi-ation in nursing home residents. Am. J. Kidney Dis. 2010;56. google scholar
• 50. Segall L, Nistor I, Van Biesen W, et al. Dialysis modality choice in elderly patients with end-stage renal disease: A narrative review of the available evidence. Nephrol. Dial. Transplant. 2017;32. google scholar
• 51. Saha M, Allon M. Diagnosis, treatment, and prevention of hemodialysis emergencies. Clin. J. Am. Soc. Nephrol. 2017;12. google scholar